There were elements of this story that may have confused readers, but the money quotes from an independent expert helped clarify the take-home message:
“It is also unclear how optimal medical management [lifestyle changes in addition to anti-platelet medication and statins] would affect overall stroke and cardiovascular risk, and stroke-free survival,” he said.
Understanding that the actions taken on the basis of test results can have both harms and benefits is key to being able to make an informed decision about the true value of the test to the individual.
The story included no discussion of costs. How much would these methods cost?
The story got the “gist” correct that surgery’s benefit increases with increasing risk. One of the saving graces of the piece was this independent perspective:
“It is also unclear how optimal medical management [lifestyle changes in addition to anti-platelet medication and statins] would affect overall stroke and cardiovascular risk, and stroke-free survival,” he said.
The story reported that 10 individuals in the study of 435 had TIAs. While transient ischemic attacks is one outcome of interest, the study presented the number of study participants that had strokes, and died of either stroke or cardiovascular death.
The story reported the likelihood that individuals with one or another of the problems visualized with ultrasound would have a stroke – but did not report the absolute increase in stroke that was actually observed. This information is essential for understanding the magnitude of benefit possible. And although the story included quotes from clinicians indicating that the risk of stroke is higher with carotid endarterectomy, there should have been some number provided to enable readers to understand the risks associated with the intervention that might result from having undergone the tests.
The story explained that the study followed 435 individuals who are known to have carotid stenosis and then followed them to see how well the two ultrasound measurements predicted those that would go on to have a stroke.
The story could have done a more complete job of explaining early on in the piece that the people studied were all 70 years of age or older, and all had known carotid stenosis. The results of this study are not generalizable to others who do not have this condition meaning that the tests should not be used for identifying those individuals with carotid plaques.
Quotes from two individuals who were not involved in the study reported on were included in this story.
Sorting throught the quotes from experts, it would seem that the combination of ultrasound tests could be used to better predict those individuals at lower risk who would be best off managed with medical therapy; and to better predict which individuals stand to benefit the most from surgery because their risk was higher.
The story is based on what was found with “two ultrasound methods.” But it never clarified whether there was something extraordinary about these methods and, if so, how well known are they? How widespread? How available?
It is really not clear from this story whether the 2 ultrasound techniques are new, are currently in use for other applications, are both in use for visualizing carotids but are not usually used in combination as in the study. Is this something new or not?
This story did not appear to rely on a news release.
Systematic, Criteria-Driven
Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's @CarlaKJohnson. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d
Come on, NY Times; you must do better than this. Important research doesn’t need hype and the “breaking news” BS doesn’t help readers or patients. https://www.healthnewsreview.org/2022/03/nyt-proclaims-breaking-news/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like